Quote:

---

Which is why I hope we do an Alzheimer's phase 2 first or have someone else fund one.

---

Ohm: Alzheimer's is one of my favorite possible indications too. My question about it is the brain blood barrier. We know that a good percentage of Leron can get through the BBB and counter inflammation there. But wouldn't we run into the same questions/problems w Alzheimer's that we've encountered with Glioblastoma, where (possibly) we might need to refigure the dosage or up the number of treatments because the amount of Leron that gets through is to a degree lessened? In other words, we might have to do a couple of Phase II trials to get to the results necessary to advance that indication. Or do you think that problem is not relevant to Alzheimer's? TIA.